PLGA-based formulations can be administered through various routes, including intravenous injection, oral delivery, and local administration. The choice of administration route depends on the type of cancer, the location of the tumor, and the specific therapeutic agent being used. Intravenous injection is often preferred for systemic delivery, while local administration can be used for targeted treatment of localized tumors.
